Come up with a name for your new list and we'll add to it:
Five Prime Therapeutics raised a round of funding on May 24, 2010. Investors include
National Multiple Sclerosis Society.
Five Prime Therapeutics is a clinical-stage biotechnology company with a pipeline of antibodies and ligand traps for cancer, autoimmunity and respiratory diseases. FivePrime has differentiated discove…